Physician profile
Bryan Hoelzer
NPI 1770558090
$717,549.20
in general payments reported to CMS, 2019-2025
17 companies · $120K in 2025
The $120K reported for 2025 was more than what 99% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90K · 2020: $102K · 2021: $130K · 2022: $99K · 2023: $71K · 2024: $105K · 2025: $120K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $234K · Travel and Lodging: $31K · Consulting Fee: $16K · Food and Beverage: $9,136 · Education: $5,507 · Entertainment: $14.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $234,311.25 |
| Travel and Lodging | $30,960.80 |
| Consulting Fee | $16,225.00 |
| Food and Beverage | $9,135.82 |
| Education | $5,506.82 |
| Entertainment | $14.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $491,851.30 | 2019-2025 | Intracept, Superion Indirect Decompression System, General - Therapies |
| Nevro Corp. | $205,244.14 | 2019-2024 | Senza |
| Medtronic USA, INC. | $9,951.41 | 2019-2020 | |
| Painteq LLC | $7,921.49 | 2023-2024 | Painteq |
| Relievant Medsystems, INC. | $1,170.07 | 2021-2023 | Intracept |
| Medtronic, INC. | $312.48 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Abbott Laboratories | $308.72 | 2024-2025 | Eterna, Proclaim |
| Globus Medical, INC. | $273.96 | 2025 | Senza |
| Biotronik Nro, INC. | $198.78 | 2024-2025 | Prospera |
| Foundation Fusion Solutions, LLC | $84.38 | 2024 | |
| Spr Therapeutics, INC | $65.93 | 2024 | Sprint Pns System |
| Stryker Corporation | $58.59 | 2025 | Optablate |
| Stimwave Technologies Incorporated | $39.27 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $21.66 | 2023 | Xtampza |
| Nalu Medical, INC. | $20.74 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.01 | 2019 | |
| Curonix LLC | $11.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Hoelzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.